medicxi is a Life Sciences venture capital firm, with offices in London, St. Helier (Jersey) and Geneva.
Employees: 11-50
Founded date: 2016
Investment Type: Venture Capital
Investment Stage: Series A; Series B
Portfolio 4
Date | Name | Website | Total Raised | Location |
23.02.2024 | Alys Pharm... | alyspharma... | $100M | - |
29.06.2022 | MiroBio | mirobio.co... | $97.03M | United Kin... |
31.08.2021 | Versanis B... | versanisbi... | $70M | United Sta... |
19.11.2020 | SynOx Ther... | synoxthera... | $81.8M | - |
Persons 19
Date | First Name | Last Name | Title | Location | |||
- | Tristan | Edwards | - | - | - | - | |
- | Giovanni | Pericolini | - | linkedin.c... | - | - | - |
- | Marie | Beaucourt | - | - | - | - | |
- | Giuseppe | Zocco | - | linkedin.c... | twitter.co... | - | - |
- | Michèle | Ollier | - | - | - | - | |
- | Francois | Prinsloo | - | - | - | - | |
- | Thibaud | Portal | - | - | - | - | |
- | Francesco | De Ruberti... | - | linkedin.c... | - | - | - |
- | Charles | Grummitt | - | - | - | - | |
- | Victoria | Taylor | - | - | - | - |
Show more
News 124
Show more
Mentions in press and media 30
Date | Title | Description | Source |
08.04.2024 | D3 Bio Completes Series A+ Round to Advance Innovative Oncol... | SHANGHAI, April 8, 2024 /PRNewswire/ -- D3 Bio, an emerging global biotechnology company that focuse... | en.prnasia... |
23.02.2024 | Alys Pharmaceuticals launches with $100M financing from Medi... | - | medicxi.co... |
11.02.2024 | Medicxi merges 6 dermatology biotechs into one, adds $100M f... | What do you get when you merge six dermatology disease-focused biotechs into one? Medicxi plans to f... | fiercebiot... |
02.10.2023 | 'The fundamentals are really strong': Why investors are stay... | While the biotech bull market hasn’t charged back in 2023 as many had hoped, European-focused ventur... | fiercebiot... |
28.07.2023 | Medicxi IV to boost the European Life sciences sector with $... | startuptic... | |
27.07.2023 | Medicxi Announces $400m Medicxi IV | - | medicxi.co... |
27.07.2023 | Medicxi Launches $400M Fund IV | Medicxi, a London, UK- Geneva, Switzerland- and Jersey-based life sciences investment firm, announce... | finsmes.co... |
19.01.2023 | The Week in Agrifoodtech: Sollum Technologies nabs $30m; pha... | Sollum Technologies raised the largest funding round this week, for its programmable LED lighting fo... | agfunderne... |
17.02.2021 | Three Cambridge spin-outs join Centessa Pharmaceuticals, lau... | Three Cambridge spin-outs join Centessa Pharmaceuticals, launched with a $250m Series A round 17-02-... | cambridgen... |
19.11.2020 | SynOx Therapeutics raises €37M in Series A Financing | DUBLIN, Nov. 19, 2020 /PRNewswire/ — SynOx Therapeutics Ltd (“SynOx”), a clinical stage bio pharmace... | incubees.c... |
Show more